Combined with the master regulator analysis results (Fig. 2g), we observed that unique metabolic processes of tRCC could be regulated by the fusion of TFE3, resulting in the upregulation of PPARGC1A expression. Here, PPARGC1A is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.